Abstract 9783: Relationship Between Abnormal P Wave Axis, Chronic Obstructive Pulmonary Disease And Mortality In The General Population
Richard KazibweMuhammad AhmadLuqman Arafath Thazhathuveetil KunahamedHaiying ChenJoseph YeboahElsayed Z SolimanInternal Medicine,Section on Hosp Medicine,Wake Forest Sch of Medicine,Winston Salem,NCInternal Medicine,Section of Hosp Medicine,Med College of Wisconsin,Milwaukee,WIBiostatistics Sciences,Wake Forest Sch of Medicine,Winston Salem,NCInternal Medicine,Section on Cardiovascular Medicine,Wake Forest Sch of Medicine,Winston Salem,NCWake Forest Sch of Medicine,Winston Salem,NC
DOI: https://doi.org/10.1161/circ.146.suppl_1.9783
IF: 37.8
2022-11-01
Circulation
Abstract:Circulation, Volume 146, Issue Suppl_1, Page A9783-A9783, November 8, 2022. Background:Vertical P-wave axis is frequently observed in the electrocardiograms (ECGs) of patients with chronic obstructive pulmonary disease (COPD). However, it is unclear whether its presence modifies the association of COPD with mortality.Methods:The analysis included 7,359 participants with ECG data from the Third National Health and Nutrition Examination Survey (NHANES-III) who were free of cardiovascular disease (CVD) at enrollment. Abnormal P-wave axis (aPWA) was defined as values above 75° from digitally recorded and centrally read ECGs. COPD was self-reported as either prior history of emphysema or a current diagnosis of chronic bronchitis. National Death Index was used to identify the date of death and cause of death. Multivariable Cox proportional hazard analysis was used to examine the association of COPD with all-cause mortality among study participants stratified by aPWA.Results:About 5.8% (n=422) and 21.8% (n=1,607) of the participants had COPD and aPWA at baseline, respectively. Over a median follow-up of 14 years, 2,435 deaths occurred. Participants with concomitant presence of aPWA and COPD (n=172) experienced higher death rates (73.9 per 1,000 person-years (PY)) compared to those with either COPD or aPWA alone (36.4 per 1,000 PY and 31.1 per 1,000 PY), respectively. In multivariable-adjusted models, there was a significant COPD by aPWA interaction (p=0.04). A stronger association between COPD and mortality was observed in the presence, compared to the absence, of aPWA. Similarly, a stronger association between aPWA and mortality was observed in the presence, compared to the absence, of COPD (Figure).Conclusions:Concomitant presence of aPWA and COPD carries a higher risk of mortality. P-wave axis, reported routinely on ECG printout, may identify a subgroup of COPD patients who are at a higher risk of poor outcomes. Further research is needed to examine whether intensive control of risk factors and disease management modify this risk.
cardiac & cardiovascular systems,peripheral vascular disease